| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/18/2002 | WO2002030413A1 Pharmaceutical solutions of modafinil compounds |
| 04/18/2002 | WO2002030412A1 Compositions containing tryptamines, carotenoids and tocotrienols having synergistic antioxidant |
| 04/18/2002 | WO2002030411A2 Treatment of apoptotic cell death |
| 04/18/2002 | WO2002030410A2 Suppression of cyclin kinase activity for prevention and treatment of infections |
| 04/18/2002 | WO2002030409A2 Methods for the treatment of a traumatic central nervous system injury |
| 04/18/2002 | WO2002030408A2 Compositions comprising phospholipase c inhibitors and methods for enhancing paracellular permeability across epithelial and endothelial barriers |
| 04/18/2002 | WO2002030407A1 ESTROGEN RECEPTOR-β LIGANDS |
| 04/18/2002 | WO2002030406A2 Use of antagonists or partial agonists of 5ht1a receptors for the preparation of a medicament for treatment and prevention of gastrointestinal diseases |
| 04/18/2002 | WO2002030405A2 Treatment of affective disorders by the combined action of a nicotinic receptor agonist and a monoaminergic substance |
| 04/18/2002 | WO2002030404A2 Combination therapy for premenstrual symptoms |
| 04/18/2002 | WO2002030399A2 Polymer controlled delivery of a therapeutic agent |
| 04/18/2002 | WO2002030396A1 Medication delivery devices |
| 04/18/2002 | WO2002030395A1 Topical antibiotic composition for treatment of eye infection |
| 04/18/2002 | WO2002030394A2 Medicinal aerosol formulations |
| 04/18/2002 | WO2002030389A1 Novel tiotropium-containing inhalation powder |
| 04/18/2002 | WO2002030385A2 Anti-inflammatory active ingredients |
| 04/18/2002 | WO2002030377A2 Product for cleaning teeth and/or the mouth |
| 04/18/2002 | WO2002030366A1 Melanogenesis inhibitors and whitening agents comprising ergosterol derivative and compositions containing ergosterol derivative |
| 04/18/2002 | WO2002030358A2 Modulation of ccr4 function |
| 04/18/2002 | WO2002030357A2 Compounds and methods for modulating ccr4 function |
| 04/18/2002 | WO2002030356A2 Synthesis of epothilones and relates analogs |
| 04/18/2002 | WO2002030355A2 Composition and method of alleviating adverse side effects and/or enhancing efficacy of agents that inhibit aromatase |
| 04/18/2002 | WO2002030354A2 Uridine therapy for patients with elevated purine levels |
| 04/18/2002 | WO2002030353A2 NF-λB INHIBITORS |
| 04/18/2002 | WO2002030257A2 Normalization of defective t cell responsiveness through manipulation of thymic regeneration |
| 04/18/2002 | WO2002017914A3 Fused pyrrolocarbazoles against inflammation |
| 04/18/2002 | WO2002012210A9 Biphenyl derivatives and their use as ppar-gamma receptor activators |
| 04/18/2002 | WO2002011697A8 A method of preparing a pharmaceutical composition |
| 04/18/2002 | WO2002011668A3 5'-deoxy-n-(substituted oxycarbonyl)-5-fluorocytosine and derivatives thereof, method of preparing same, and anticancer composition comprising same as active ingredients |
| 04/18/2002 | WO2002009815A3 New pharmaceutical composition |
| 04/18/2002 | WO2002009814A3 New use of lipase inhibitors |
| 04/18/2002 | WO2002009682A3 Use of fibrates for the preparation of a medicament useful in the treatment of congestive heart failure |
| 04/18/2002 | WO2002009679A3 Use of 13-cis retinoic acid for the treatment of emphysema |
| 04/18/2002 | WO2002008217A3 COUMARIN DERIVATIVES USEFUL AS TNFα INHIBITORS |
| 04/18/2002 | WO2002008177A8 N-substituted-1-amino-1,1-dialkylcarboxylic acid derivatives |
| 04/18/2002 | WO2002007738A8 Combinations of chitosan and psyllium for synergistic adsorption of triglyceride and cholesterol |
| 04/18/2002 | WO2002007721A3 Use of cox-2 inhibitors for preventing immunodeficiency |
| 04/18/2002 | WO2002003995A3 Treatment of male sexual dysfunction |
| 04/18/2002 | WO2002002541A3 Inhibitors of copper-containing amine oxidases |
| 04/18/2002 | WO2002000201A3 Method for preparing a composition |
| 04/18/2002 | WO2002000163A3 The method of treating drug resistant mycobacterium tuberculosis infection |
| 04/18/2002 | WO2001096353A3 3'-PRODRUGS OF 2'-DEOXY-β-L-NUCLEOSIDES |
| 04/18/2002 | WO2001093902A3 Immunostimulatory rna/dna hybrid molecules |
| 04/18/2002 | WO2001093806A3 HMG CoA REDUCTASE INHIBITORS FOR PROMOTING ANGIOGENESIS |
| 04/18/2002 | WO2001091748A3 Methods for prevention of ulcers and improving physiological performance |
| 04/18/2002 | WO2001091732A3 Medicament for combating respiratory depression |
| 04/18/2002 | WO2001087830A3 Substituted thioacetamides |
| 04/18/2002 | WO2001087272A3 Encapsulating a toxic core within a non-toxic region in an oral dosage form |
| 04/18/2002 | WO2001087229A3 Treating infections |
| 04/18/2002 | WO2001082969A3 Medicines for treating tumoral pathologies containing the ro5-4864 compound and an apoptosis-inducing agent |
| 04/18/2002 | WO2001081574A3 Regulation of nf-at interacting protein nip 45 variant |
| 04/18/2002 | WO2001080807A3 Medicine containing polysaccharide substances for activating apoptosis |
| 04/18/2002 | WO2001077357A3 Chromosomal vectors and uses thereof |
| 04/18/2002 | WO2001072289A3 Medicament for the stimulation of leucopoiesis and treatment of tumour and protozoan diseases acarinosis and arthropod-borne diseases and a method for production thereof |
| 04/18/2002 | WO2001070209A3 Mono- and disaccharides for the treatment of nitric oxide related disorders |
| 04/18/2002 | WO2001068912A3 Diagnosis of diseases associated with tumor suppressor genes and oncogenes |
| 04/18/2002 | WO2001068570A3 Il-8 receptor antagonists |
| 04/18/2002 | WO2001068569A3 Il-8 receptor antagonists |
| 04/18/2002 | WO2001068075A3 Method for increasing intestinal absorption of fat soluble vitamins in post-menopausal women and lower animals |
| 04/18/2002 | WO2001068070A3 Use of spirolaxin for the treatment of diseases associated with abnormal angiogenesis |
| 04/18/2002 | WO2001066595A3 Human fgf-23 gene and gene expression products |
| 04/18/2002 | WO2001064681A3 3-(pyrolyllactone)-2-indolinone compounds as kinase inhibitors |
| 04/18/2002 | WO2001062709A3 Use of 2-phenylene diamine derivatives for the treatment of infections |
| 04/18/2002 | WO2001060400A3 Use of inhibitors of caspase-3 or caspase-activated desoxyribonuclease (cad) for treating cardiac disease |
| 04/18/2002 | WO2001060378A3 Antiadhesive carbohydrates |
| 04/18/2002 | WO2001060377A3 Methods for treatment of lysosomal storage diseases using biphosphonates |
| 04/18/2002 | WO2001060345A3 Pharmaceutical composition comprising squalene epoxidase inhibitor and macrolide immunomodulator |
| 04/18/2002 | WO2001060318A3 Protection of the female reproductive system from natural and artificial insults |
| 04/18/2002 | WO2001058916A3 Antibodies to ccr5 |
| 04/18/2002 | WO2001058893A3 Indol-3-yl derivatives and their use as integrin inhibitors |
| 04/18/2002 | WO2001055101A3 A new process for the preparation of latanoprost |
| 04/18/2002 | WO2001052828A3 Glutamine prevention of delayed-onset irinotecan-induced diarrhea |
| 04/18/2002 | WO2001051025A3 Formulations of active components in the form of a solid dispersion |
| 04/18/2002 | WO2001045691A3 Method of treating gastrointestinal tract disease with purinergic receptor agonists |
| 04/18/2002 | WO2001040271A3 Cancer associated antigens and uses therefor |
| 04/18/2002 | WO2001039738A3 Use of flavones and/or isoflavones from plant extracts |
| 04/18/2002 | WO2001034202A3 Depletion of cellular coenzyme-a levels as a means to selectively kill cancer cells |
| 04/18/2002 | WO2001026656A3 5-membered heterocycle derivatives and use thereof as monoamine oxidase inhibitors |
| 04/18/2002 | WO2001026644A3 Mediators of hedgehog signaling pathways, compositions and uses related thereto |
| 04/18/2002 | WO2001025437A3 Growth factor polypeptides and nucleic acids encoding same |
| 04/18/2002 | WO2001005253A8 Compositions, kits, and methods for providing and maintaining energy and mental alertness |
| 04/18/2002 | WO2000071752A9 Assay for the detection of paclitaxel resistant cells in human tumors |
| 04/18/2002 | WO2000070341A9 Methods, pharmaceutical formulations and kits for identification of subjects at risk for cancer |
| 04/18/2002 | WO2000066106A9 Use of benzodiazepines for treating autoimmune diseases induced by apoptosis |
| 04/18/2002 | US20020045777 Used to treat hypercholesterolemia, hyperlipemia, arteriosclerosis, vascular diseases, mycoses, gallstones, hyperproliferative disorders, and treatment and/or prophylaxis of impaired glucose tolerance and diabetes. |
| 04/18/2002 | US20020045774 Antigestagenically active steroids with a fluorinated 17-alpha-alkyl chain |
| 04/18/2002 | US20020045772 E.g., 2 beta-(2-iodoethyloxy)-1 alpha ,3 beta ,25-tris(triethylsilyloxy)cholesta-5,7-diene |
| 04/18/2002 | US20020045768 Preparation of cyclohexene derivatives intermediates for carotinoids using a mixture of zinc and a salt of ammonium, copper, alkali metal or alkaline earth metal as reducing agent |
| 04/18/2002 | US20020045765 Tocopherol derivatives and method for preparation thereof |
| 04/18/2002 | US20020045761 Five-membered heterocycles having biphenylsulfonyl substitution, process for their preparation, their use as a medicament or diagnostic, and medicament comprising them |
| 04/18/2002 | US20020045759 E.g., N-(2-Phenylsulfonyl-1-ethyl)-3-(4-Cyanophenyl)-2,3-dihydro-imidazo(2,1 -b)thiazole-5-carboxamide hydrochloride; treating cancer, neurofibromin benign proliferative disorder, retinal vascularization, and hepatitis delta |
| 04/18/2002 | US20020045753 E.g., (S)-N-(4-(4-((3,4-dihydro-6-hydroxy-2,5,7,8-tetramethyl-2H-1-benzopyran-2 -yl)-carbonyl)-1-piperazinyl)phenyl)-2-thiophenecarboximidamide , or a salt thereof. |
| 04/18/2002 | US20020045749 Antibacterial agents |
| 04/18/2002 | US20020045747 Treating Alzheimer's disease both prophylactically and therapeutically |
| 04/18/2002 | US20020045669 Novel class of polyamines without the side effects of Class I-IV compounds |
| 04/18/2002 | US20020045668 Compositions for sustained release of analgesic agents, and methods of making and using the same |
| 04/18/2002 | US20020045667 Non-toxic antimicrobial compositions and methods of use |
| 04/18/2002 | US20020045665 Prostaglandin compositions and methods of treatment for male erectile dysfunction |
| 04/18/2002 | US20020045664 Estrogen mimetics lacking reproductive tract effects |
| 04/18/2002 | US20020045663 Treating cancer in a patient comprising administering an effective amount of substantially purified D enantiomer of difluoromethylornithine |